GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 128 filers reported holding GOSSAMER BIO INC in Q3 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $4,516,000 | -22.9% | 377,000 | -46.1% | 2.98% | -44.2% |
Q2 2022 | $5,859,000 | +50.0% | 700,000 | +55.6% | 5.34% | +84.5% |
Q1 2022 | $3,906,000 | -27.3% | 450,000 | -5.3% | 2.90% | +54.2% |
Q4 2021 | $5,372,000 | -63.6% | 475,000 | -59.6% | 1.88% | -56.8% |
Q3 2021 | $14,770,000 | +54.8% | 1,175,000 | 0.0% | 4.34% | +83.2% |
Q2 2021 | $9,541,000 | – | 1,175,000 | – | 2.37% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |